Walleye Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10M Buy
45,200
+43,600
+2,725% +$9.5M 0.01% 1267
2026
Q2
$312K Sell
1,600
-3,800
-70% -$788K ﹤0.01% 3145
2026
Q1
$1.21M Sell
5,400
-200
-4% -$49.8K 0.01% 1901
2025
Q4
$1.35M Buy
5,600
+1,700
+44% +$435K ﹤0.01% 2190
2025
Q3
$1.07M Sell
3,900
-5,900
-60% -$1.61M ﹤0.01% 2039
2025
Q2
$2.53M Sell
9,800
-3,600
-27% -$859K 0.01% 1338
2025
Q1
$3M Buy
13,400
+5,900
+79% +$1.38M 0.01% 1137
2024
Q4
$1.72M Sell
7,500
-14,200
-65% -$3.42M ﹤0.01% 1917
2024
Q3
$5.3M Sell
21,700
-3,100
-13% -$693K 0.01% 1133
2024
Q2
$4.75M Buy
24,800
+8,000
+48% +$1.62M 0.01% 1331
2024
Q1
$3.33M Buy
16,800
+8,200
+95% +$1.5M 0.01% 1612
2023
Q4
$1.48M Buy
8,600
+5,500
+177% +$845K ﹤0.01% 2030
2023
Q3
$458K Buy
3,100
+500
+19% +$90.4K ﹤0.01% 2884
2023
Q2
$568K Sell
2,600
-1,500
-37% -$334K ﹤0.01% 2338
2023
Q1
$898K Buy
+4,100
New +$890K 0.01% 1236
2020
Q1
– Sell
-100
Closed -$15K – 1530
2019
Q4
$15K Buy
+100
New +$14.4K ﹤0.01% 1624

Other funds holding RMD

Walleye Capital's RMD Position: Q3 2026 in Review

Walleye Capital reduced its ResMed (RMD) stake by 90% in Q3 2026, selling an estimated $16.6M and leaving 8,766 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Walleye Capital first reported a position in RMD in Q2 2019 and has held it in 13 quarters since. The position peaked at $16.6M in Q2 2026. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Walleye Capital held 8,766 shares of ResMed worth $1.94M as of Q3 2026.
  • Walleye Capital sold 76,179 ResMed shares in Q3 2026, an estimated $16.6M.
  • ResMed made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2862 holding.
  • Walleye Capital first reported a position in ResMed in Q2 2019 and has held it in 13 quarters since.
  • Walleye Capital's ResMed position peaked at $16.6M in Q2 2026.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.